Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antiviral activity against VACV
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed Citation
Antiviral activity against vaccinia virus infected in human HepG2 cells assessed as reduction in plaque formation
Inhibition of Vaccinia virus VP39 expressed in Escherichia coli C2566 at upto 50 uM
Assay data:1 Tested
SummaryPubMed Citation
Inhibition of Vaccinia virus mRNA-capping enzyme D1/D12 subunit complex expressed in Escherichia coli C2566 at upto 50 uM
Antiviral activity against Vaccinia virus infected in HEL cells assessed as reduction in virus-induced cytopathic effect by microscopic analysis
Assay data:6 Tested
Invivo antiviral activity against Vaccinia virus infected in mouse assessed as reduction in virus severity of virus induced tail lesion at 250 mg/kg, po measured after 24 to 48 hrs relative to control
Antiviral activity against vaccinia virus infected in cells assessed as viral infection at 10 uM
Inhibition of p37 in Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as reduction in viral reproduction incubated for 4 days by neutral red dye based colorimetric analysis
Assay data:14 Active, 5 Activity ≤ 1 µM, 19 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Antiviral activity against Vaccinia virus
Assay data:21 Tested
Antiviral activity against Vaccinia virus infected in human HEL cells assessed as reduction in virus-induced cytopathic effect incubated for 3 to 6 days by light microscopic analysis
Assay data:16 Tested
Inhibition of 2'-O-methyltransferase activity of Vaccinia virus VP39 at 200 uM
Inhibition of N7-MTase activity of Vaccinia virus mRNA capping enzyme D1/D12 complex using GpppAC4 and [3H]SAM as substrate at 50 uM preincubated with enzyme followed by substrate addition and measured after 30 mins by filter binding assay
Assay data:17 Tested
Assay data:2 Active, 2 Tested
Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as reduction in cell survival incubated for 4 days by neutral red dye based colorimetric analysis
Assay data:15 Active, 3 Activity ≤ 1 µM, 20 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against Vaccinia virus assessed as reduction in viral reproduction at 2 ug/ml relative to control
Antiviral activity against Vaccinia virus assessed as reduction in viral reproduction at 2 ug/ml after 3 hrs relative to control
Antiviral activity against Vaccinia virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by microscopic analysis
Assay data:18 Tested
Antiviral activity against Vaccinia virus infected in human HFF cells
Antiviral activity against Vaccinia virus Copenhagen infected in human HFF cells
Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity
Assay data:20 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on